This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Levine, S. P. Articles by Krentz, L. S. Search for Related Content PubMed PubMed Citation Articles by Levine, S. P. Articles by Krentz, L. S.

Circulation, Vol 64, 626-632, Copyright © 1981 by American Heart Association

ARTICLES

Increased plasma concentrations of platelet factor 4 in coronary artery disease: a measure of in vivo platelet activation and secretion

SP Levine, J Lindenfeld, JB Ellis, NM Raymond and LS Krentz

Previous studies have shown that there is both a significant shortening in platelet survival and a measured hyperactivity to platelet- aggregating agents in patients with documented coronary artery disease compared with control groups. We used a recently described radioimmunoassay for the platelet-secreted protein platelet factor 4 (PF4) to study 162 patients with documented coronary artery disease. There was a significant increase in plasma PF4 concentrations in patients with documented coronary artery disease compared with angiographically normal patients (8.7 vs 16 ng/ml, respectively, n = 121), but as in previous studies of platelet survival, we could not correlate elevated plasma PF4 concentration and the severity or site of the coronary artery disease. In addition, there was no correlation with left ventricular function, serum cholesterol or the type of angina. Patients with confirmed acute myocardial infarction had no significant difference in mean plasma PF4 concentrations compared with similar groups of coronary disease patients who had prolonged chest pain or chronic stable angina. Coronary artery bypass grafting in a subgroup of patients did not affect the mean plasma PF4 concentration during 1 year of follow-up after bypass surgery, but medical therapy for angina with increasing doses of propranolol and nitrates significantly reduced PF4 concentration in another subgroup of patients who were not considered to be candidates for surgical therapy.

This article has been cited by other articles:

				C. J. Knight, M. Panesar, C. Wright, D. Clarke, P. S. Butowski, D. Patel, A. Patrineli, K. Fox, and A. H. Goodall Altered Platelet Function Detected by Flow Cytometry : Effects of Coronary Artery Disease and Age Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2044 - 2053. [Abstract] [Full Text]

				S.G. Thompson, C. Fechtrup, E. Squire, U. Heyse, G. Breithardt, J.C.W. van de Loo, and J. Kienast Antithrombin III and Fibrinogen as Predictors of Cardiac Events in Patients With Angina Pectoris Arterioscler Thromb Vasc Biol, March 1, 1996; 16(3): 357 - 362. [Abstract] [Full Text]